Perimeter Medical Imaging AI is a pioneering medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs. Our goal is to improve patient outcomes and lower health care costs.
Cancer is a global challenge, and we envision a world where patients no longer experience the costly emotional and physical trauma of being called back for a second surgery due to cancer left behind.
A Toronto, Canada-based company established in 2013, with U.S. headquarters in Dallas, Texas, our proprietary technology allows surgeons to make more informed decisions during the surgical procedure. Until now, current technologies in the OR have not had the image resolution to identify microscopic features of excised tissues and shaved margins at the point-of-care. Our new OCT technology gives them real-time information vs. waiting several days for pathology reports.
Perimeter S-Series OCT (Optical Coherence Tomography) is a groundbreaking medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens. It uses ultra-high-resolution OCT technology, developed out of MIT in 1991, an established imaging technology used in ophthalmology, cardiology and dermatology. Analogous to ultrasound images, OCT uses light waves instead of sound waves, and is now being applied in a novel way for intraoperative margin visualization.
Cleared by the FDA, the Perimeter S-Series system provides cross-sectional images of tissues down to 2mm depth, with 10x higher image resolution than standard x-ray and ultrasound, and 100x greater than MRI.
Perimeter is developing its proprietary, next-gen “ImgAssist” artificial intelligence technology under the ATLAS AI project, made possible, in part, by a $7.4 million grant awarded by the Cancer Prevention and Research Institute of Texas (CPRIT). The U.S. FDA granted Breakthrough Device Designation for Perimeter B-Series OCT coupled with ImgAssist AI. A randomized, multi-site, pivotal study is underway to evaluate this technology against the current standard of care and assess the impact on re-operation rates for patients undergoing breast conservation surgery.
Cancer is a global challenge, and we envision a world where patients no longer experience the costly emotional and physical trauma of being called back for a second surgery due to cancer left behind.
A Toronto, Canada-based company established in 2013, with U.S. headquarters in Dallas, Texas, our proprietary technology allows surgeons to make more informed decisions during the surgical procedure. Until now, current technologies in the OR have not had the image resolution to identify microscopic features of excised tissues and shaved margins at the point-of-care. Our new OCT technology gives them real-time information vs. waiting several days for pathology reports.
Perimeter S-Series OCT (Optical Coherence Tomography) is a groundbreaking medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens. It uses ultra-high-resolution OCT technology, developed out of MIT in 1991, an established imaging technology used in ophthalmology, cardiology and dermatology. Analogous to ultrasound images, OCT uses light waves instead of sound waves, and is now being applied in a novel way for intraoperative margin visualization.
Cleared by the FDA, the Perimeter S-Series system provides cross-sectional images of tissues down to 2mm depth, with 10x higher image resolution than standard x-ray and ultrasound, and 100x greater than MRI.
Perimeter is developing its proprietary, next-gen “ImgAssist” artificial intelligence technology under the ATLAS AI project, made possible, in part, by a $7.4 million grant awarded by the Cancer Prevention and Research Institute of Texas (CPRIT). The U.S. FDA granted Breakthrough Device Designation for Perimeter B-Series OCT coupled with ImgAssist AI. A randomized, multi-site, pivotal study is underway to evaluate this technology against the current standard of care and assess the impact on re-operation rates for patients undergoing breast conservation surgery.
Location: Canada, Ontario, Toronto
Employees: 11-50
Phone: +1 214-845-5154
Total raised: $12.44M
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | Keiretsu F... | keiretsufo... |
| - | Golden Tri... | goldentria... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.04.2020 | Grant | $7.44M | - |
| 22.07.2015 | Series A | $5M | - |
Mentions in press and media 26
| Date | Title | Description |
| 05.06.2025 | Perimeter Medical Launches OCT-Tissue Surveillance Registry to Advance AI in Surgical Imaging | What You Should Know: – Perimeter Medical Imaging AI, Inc., a medical technology company, is set to advance the capabilities of its surgical imaging solutions with the establishment of the OCT-Tissue Surveillance Registry. – The database wi... |
| 30.03.2023 | Perimeter Medical Imaging AI Announces Publication of New Clinical Evidence Featuring Case Studies from Commercial Use of Perimeter S-Series OCT | Perimeter Medical Imaging AI, Inc. a commercial-stage medical technology company – announced the publication of a new white paper entitled “Use of adjunct wide-field optical coherence tomography to visualize margins during breast conserving... |
| 14.02.2023 | The Medical Imaging AI Company Raises €10 Million In Series A Funding For Global Growth | Avicenna.AI, a medical imaging AI company, has announced that it has raised a Series A funding round, bringing its total investment to €10 million. The round was backed by existing investors Innovacom and CEMAG Invest. The funds will be use... |
| 05.12.2022 | Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use | Research concludes WF-OCT allowed for real-time margin visualization of excised oral and oropharyngeal tissue without impacting specimen integrity or surgical and pathology workflows Perimeter Medical Imaging AI, announced the publication o... |
| 16.11.2022 | Perimeter Medical Imaging AI Announces Follow-On Commercial Placement of Perimeter S-Series OCT | Perimeter Medical Imaging AI, announced another commercial placement of its flagship Perimeter S-Series OCT system at a second hospital within one of the largest healthcare networks in North Texas, which is part of a major national healthca... |
| 10.08.2021 | AI For Population Health And Medical Imaging Gets A Boost With $230 Million Acquisitions | - |
| 13.05.2021 | To expand or not to expand? Houston researcher weighs in on global growth | You built your business from the ground up, patiently finding techniques and products that work, carefully crafting solid bonds with your clients. Then one day a new project, opportunity or simple request poses a question: Is it time to bra... |
| 11.05.2021 | Global accelerator announces 5 startups to its Houston cohort | Five Houston companies have been tapped to participate in a Houston-based, early-stage startup accelerator with a national presence. The accelerator, gBETA, selected the five Houston companies out of over 85 applicants. The cohort represent... |
| 10.05.2021 | Energy giant makes Houston sole headquarters in massive move | Power player NRG Energy is laser focused on Houston. The Bayou City will be the energy giant's new sole headquarters; the company will no longer split between Houston and Princeton, New Jersey. The move to a single headquarters simplifies b... |
| 30.03.2021 | Biotechs Working on Potential Preventive Measures and Cancer Treatments | FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, March 30, 2021 /PRNewswire/ -- Cancer research and development are a major part of the biotechnology industry, and there is always room for improvement and growth. Recent... |
Show more